October 2017 ARTICLE LIST >>
PharmaTutor (October - 2017)
ISSN: 2347 - 7881
(Volume 5, Issue 10)
Received On: 07/06/2017; Accepted On: 20/06/2017; Published On: 01/10/2017
AUTHORS:
M. Manasa Rekha*, T.Mubeena,
Department of Pharmacy Practice,
Annamacharya college of Pharmacy,
Rajampet, Y.S.R kadapa district, Andhra Pradesh, India.
*manasarekharoyal@gmail.com
ABSTRACT:
The area of the pharmacy concerned with science and practice of rational usage of the drugs. The clinical pharmacist is the one of the member in the health care team. clinical pharmacists provide care to their patients and that this practice can occur in any practice setting. Drug Utilization Reviews (DUR), also referred to as Drug Utilization Evaluations (DUE) or Medication Utilization Evaluations (MUE), are defined as an authorized, structured, ongoing review of healthcare provider prescribing, pharmacist dispensing, and patient use of medication. DURs involve a comprehensive review of patients' prescription and medication data before, during, and after dispensing to ensure appropriate medication decision making and positive patient outcomes.
How to cite this article: Rekha MM, Mubeena T; A study on role of Doctor of Pharmacy in Drug Utilization Evaluation Pattern Analysis in inpatient units and reporting its comorbidities in a tertiary care teaching hospital; PharmaTutor; 2017; 5(10); 55-62
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. M. Manasa rekha ,A. Bharath kumar -- a prospective study on implementation of clinical pharmacy services to general medicine department in a teritary care teaching hospital published in journal of pharma research in ISSN: 2319-5622.
2. American College of Clinical Pharmacy; Pharmacotherapy 2008; 28(6); 816–817.
3. American College of Clinical Pharmacy; The Definition of Clinical Pharmacy. Pharmacotherapy 2008; 28(6); 816-817.
4. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA; Do pharmacists’ presences on rounding teams reduce preventable adverse drug events in hospital general medical units; CMAJ; 2004; 170(3); 333.
5. Roberts MS , Stokes JA , King MA, Lynne TA, Purdie DM; Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes; Br J Clin Pharmacol; 2001; 51; 257-265.
6. Langebrake C, Hilgarth H. Clinical Pharmacist intervention in German University Hospital. Pharm World Sci 2010; 32; 194-199.
7. Srinivasan R, Ramya G. Adverse drug reaction-causality assessment; International journal of research in pharmacy and chemistry; 2011; 1(3); 606-612
8. Rajaram G, Sugirda, P and Lenin R; Pattern of adverse cutaneous drug reactions presenting to general practitioners in a semi urban area; asian journal of science and technology; 2005; 6(9); 1788-1790
9. Jean F Kozak and Akber Mithani; Prevalence of Adverse Drug Events in Long Term Care: Variations in Screening between Nurses and Physician-Pharmacist Reviewers; HSOA Journal of Gerontology & Geriatric Medicine; 2015; 1; 07.
10. American College of Clinical Pharmacy Board of Regents on April 8, 2005. 13000 West 87th Street Parkway, Suite100, Lenexa, KS 66215-4530;
11. Chacko Jiyo, Satish D; Suthar et al; Drug utilization study of HIV positive patients registered with antiretroviral therapy centre of a tertiary care hospital.
12. National AIDS Control Organization, Govt of India, New Delhi. www.nacoonline.org.
13. Jigar D Kapadia, Chetna K Desai; A study of utilization pattern, efficacy and safety of drugs prescribed for opportunistic infections in HIV infected patients. 2014; 4(3); 200-209
14. Ragesh G., Sindhubharathi A, Ushasri M, Srinivasulu A. A Study on Assessment Of Clinical Pharmacy Services To Cardiology Department In Tertiary Care Teaching Hospital. Int J Pharm Pharm Sci; 2015; 6(2); 192-195
15. Satish Kumar BP, Prasanna Dhalal, Rajesh Venkataraman. Assessment of Clinical Pharmacist Intervention in Tertiary Care Teaching Hospital of southern India, Asian journal of pharmaceutical and clinical research, 2013; 6; 258-261.
.png)
